Kemoplat 50 Injection

• Lung cancer,
• Ovarian cancer,
• Cervical cancer

• Injection site reactions
• pain,
• swelling,
• redness,
• Increased risk of infection,
• Ear damage,
• Vomiting,
• Nausea,
• Decreased blood cells (red cells, white cells, and platelets),
• Renal impairment,
• Peripheral neuropathy (tingling and numbness of feet and hand),
• Kidney damage,
• Hearing loss,
• Ringing in ear,
• Back pain,
• Fever or chills,
• Joint pain,
• Tinnitus or buzzing Swelling of feet and calves,
• Decreased taste Convulsions (seizures),
• Sour mouth Blurred vision,
• Nausea and vomiting,
• Loss of appetite.

• Altretamine,
• Anticonvulsant agents,
• Pyridoxine.
• Neurotoxicity,

  usually characterized by peripheral neuropathy, has been reported. Neuropathy usually occurs after long-term treatment; however, neurological symptoms have been reported to occur after a single dose.

  Although symptoms and signs of kemoplat 50 mg neuropathy usually appear during treatment, symptoms of neuropathy may begin 3 to 8 weeks after the last dose of Kemoplat.

  When symptoms are first observed, Kemoplat treatment should be stopped.

  However, even if treatment is stopped, neuropathy may develop further.

  Preliminary evidence suggests that peripheral neuropathy in some patients may be irreversible

Do not freeze kemoplat 50mg injection reviews unless required by package insert. Keep medicines away from children and pets.

Do not flush medications down the toilet or pour them into drainage unless instructed to do so.

Medication discarded in this manner may contaminate the environment.

Please consult your pharmacist or doctor for more details on how to safely discard Kemoplat 50mg Injection.